Early Morphological Changes After Total Gastrectomy in the Rat Pancreas

Total gastrectomy is widely used as a major surgical treatment for gastric cancer. The aims of this study were to investigate the possible effects of total gastrectomy on pancreas morphology, and to determine the immunolocalisation of chromogranin A (Cg A) and synaptophysin (SYP) antigens, described as specific tumour markers for neuroendocrine tumours. Ten rats underwent total gastrectomy via oesophago-duodenostomy. After a month the rats were killed, and tissue samples were taken from the pancreas, processed for light microscopy and stained with haematoxylin-eosin. In addition, 5-7 µm thick paraffin embedded tissue sections were immunohistochemically stained with Cg A and SYP. The acinar cells showed abundant cytoplasm which contained numerous zymogen granules in the experimental group animals in comparison with the control group. The islets of Langerhans showed significant hyperplasia postoperatively when compared to the control group. Strong immunoreactivity for Cg A and SYP was seen in the islet cells. It may be suggested that total gastrectomy causes adverse morphological changes in the pancreas. Strong Cg A and SYP immunoreactivities may be a relevant marker for pancreatic cancers in the early postoperative period after total gastrectomy.

Anahtar Kelimeler:

Pancreas, total gastrectomy, chromogranin A (Cg A), synaptophysin (SYP).

Early Morphological Changes After Total Gastrectomy in the Rat Pancreas

Keywords:

Pancreas, total gastrectomy, chromogranin A (Cg A), synaptophysin (SYP).,

PDF

___

Caygill, C.P.J, Hill, M.J., Hall, C.N., Kirkham, J.S., Northfield T.C.: Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer. Gut, 1987; 28: 924-928.
Tersmette, A.C., Offerhaus, J.A., Giardiello, F.M., Tersmette, K.W.F., Vanderbroucke, J.P., Tytgat, G.N.J.: Occurrence of non- gastric cancer in the digestive tract after remote partial gastrectomy; analysis of an Amsterdam cohort. Int. J. Cancer, 1990; 46: 792-795.
Bradley, E.L., Isaac, F.J., Hersh, T., Davidson, E.D., Millikan, W.: Nutritional consequences of total gastrectomy. Ann. Surg., 1975; 182: 415-429. 4. Zittel, T.T., Vonelm, B., Teichmann, R.K., Rabould, H.E., Becker, H.D.: Cholecystokinin is partly responsible for reduced food intake and body weight loss after total gastrectomy in rats. Am. J. Surg., 1995; 169: 265-270.
Ross, A.H.M., Smith, M.A., Anderson, J.R., Small, W.P.: Late mortality after surgery for peptic ulcer. New Engl. J. Med., 1982; 307: 519-522. 6. Mills, P.K., Beeson, W.L., Abbey, D.E., Fraser, G.E., Phillips R.L.: Dietary habits and past medical history as related to fatal pancreas cancer risk among adventists. Cancer, 1988; 61: 2578-2585.
Tanigawa, H., Uesugi, H., Mitomi, H., Saigenji, K., Okayasu, I.: Possible association of active gastritis, featuring accelerated cell turnover and P53 overexpression with cancer development at anastomoses after gastrojejunostomy. Comparison with gastroduodenostomy. Am. J. Clin. Pathol., 2000; 114: 354-363.
Rainey, J.B., Davies, P.W., Williamson, R.C.N.: Relative effects of ileal resection and bypass on intestinal adaptation and carcinogenesis. Brit. J. Surg., 1984; 71: 197-202.
Houghton, P.W.J., Mortensen, N.J.M, Williamson, R.C.N.: Effect of duodenogastric reflux on gastric mucosal proliferation after gastric surgery. Brit. J. Surg., 1987; 74: 288-291.
Allen, T.C.: Hematoxylin and Eosin. In: Prophet, E.B., Mills, B., Arrington, J.B., Sobin, L.H.: Laboratory Methods in Histotechnology. American Registry of Pathology, D.C., 1992; 53-58.
Axelson, J., Persson, P., Gagnemo-Persson, R., Hakanson, R.: Importance of the stomach in maintaining calcium homoeostasis in the rat. Gut, 1991; 32: 1298-1302.
Li Destri, G., Trombatore, G., La Greca, G., Rinzivillo, C., Rodolico, M., Desiderlo, C., Orsina, N., Di Cataldo, A., Puleo, S.: Total gastrectomy: Nutritional status after different reconstruction techniques. An experimental study. J. Surg. Onc., 1992; 49: 98-102.
Buchler, M., Malfertheiner, P., Glasbrenner, B., Beger, H.G.: Rat exocrine pancreas following total gastrectomy. Int. J. Pancreatol., 1986; 1: 389-398.
Malfertheiner, P., Büchler, M., Glasbrenner, B., Schafmayer, A., Ditschuneit, H: Adaptive changes of the exocrine pancreas and plasma cholecystokinin release following subtotal gastric resection in rats. Digestion, 1987; 38: 142-151.
Buchler, M., Malfertheiner, P., Glasbrenner, B., Beger, H.G.: Pancreatic trophism after truncal vagotomy in rats. Am. J. Surg., 1987; 154: 300-304.
Wormsley, K.G.: The effect of vagotomy on the human pancreatic response to direct and indirect stimulation. Scand. J. Gastroenterol., 1972; 7: 85-91.
Jakob, S., Mosenthin, R., Zabielski, R., Rippe, C., Winzell, M.S., Gacsalyi, U., Laubitz, D., Grzesiuk, E., Pierzynowski, S.G.: Fats infused intraduodenally affect the postprandial secretion of the exocrine pancreas and the plasma concentration of the cholecystokinin but not of peptide YY in growing pigs. J. Nutr., 2000; 130: 2450-2455.
Compfield, A.L., Smith, F.J., LeMagnen, J: Altered endocrine pancreatic function following vagotomy: possible behavioral and metabolic bases for assessing completeness of vagotomy. J. Auton. Nerv. Syst., 1983; 9: 283-300.
Humphrey, C.S., Dykes, J.R.W. Johnson D.: Effects of truncal, selective and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Brit. Med. J., 1975; 2: 112-116.
Roth, D.A., Meade, R.C.: Hyperinsulinism-hypoglycemia in the postgastrectomy patient. Diabetes, 1965; 14: 526-528.
Chejfec, G., Falkmer, S., Grimelius, L., Jacobsson, B., Rodensjo, M., Wiedenmann, B., Franke, W.W., Lee, I., Gould, V.E.: Synaptophysin: A new marker for pancreatic neuroendocrine tumors. Am. J. Surg. Pathol., 1987; 11: 241-247.
Hoorens, A., Lemoine, N.R., McLellan, E., Morohoshi, T., Kamisawa, T., Heitz, P.U., Stamm, B., Ruschoff, J., Wiedenmann, B., Kloppel, G.: Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p 53 expression, and Ki-ras mutation. Am. J. Pathol., 1993; 143: 685-689.
Tsao, K-C., James, T.W.U.: Development of an ELISA for the detection of serum chromogranin A (CgA) in prostate and non- neuro-endocrine carcinomas. Clin. Chim. Acta., 2001; 313: 21- 29.